Zhejiang Ausun Pharmaceutical Co., Ltd. (603229.SS)
Zhejiang Ausun Pharmaceutical Co., Ltd., engages in the research, development, production, and sale of pharmaceutical formulations, specialty active pharmaceutical ingredients (APIs), and pharmaceutical intermediates in China and internationally.
7.42+0.02%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-39.7%
The outlook
Zhejiang Ausun Pharmaceutical Co., Ltd. currently reads as bearish based on below its 50- & 200-day averages, 5% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range5% of the way from its 52-week low to high
Market cap
$6.16B
52-wk high
12.51
52-wk low
7.15
50-day avg
8.51
200-day avg
9.53
Trailing P/E
53.0
Similar stocks
600645.SSVcanbio Cell & Gene Engineering Corp., Ltd$18.77+1.02%603566.SSPulike Biological Engineering, Inc.$10.39+1.07%603718.SSShanghai Hile Bio-Technology Co., Ltd.$2.86+4.00%603896.SSZhejiang Shouxiangu Pharmaceutical Co., Ltd.$14.82+1.58%603590.SSBeijing Konruns Pharmaceutical Co.,Ltd.$29.76+0.88%